These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 20179260)

  • 21. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
    Perfect JR; Dodds Ashley E; Drew R
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
    Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
    Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of anti-fungal management in lung transplantation.
    Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
    J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is universal antifungal prophylaxis mandatory in lung transplant patients?
    Schaenman JM
    Curr Opin Infect Dis; 2013 Aug; 26(4):317-25. PubMed ID: 23743815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
    Miguélez M; Lumbreras C; Herrero JA; Aguado JM; del Palacio A; Colina F; Gómez R; Lizasoain M; Moreno E; Rodríguez-Noriega A
    Med Clin (Barc); 1998 Mar; 110(11):406-10. PubMed ID: 9608495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data.
    Muñoz P; Guinea J; Narbona MT; Bouza E
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S125-31. PubMed ID: 19013336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
    Chandrasekar P; Ljungman PT
    Transplantation; 2008 Jul; 86(2):183-91. PubMed ID: 18645475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in antifungal prophylaxis strategies in lung transplantation.
    Husain S; Zaldonis D; Kusne S; Kwak EJ; Paterson DL; McCurry KR
    Transpl Infect Dis; 2006 Dec; 8(4):213-8. PubMed ID: 17116134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
    Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
    Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM
    Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.
    Kontoyiannis DP
    Bone Marrow Transplant; 2011 Feb; 46(2):165-73. PubMed ID: 21042306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.
    Cornely OA
    Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.